BACKGROUND: Transient ischemic dilation (TID) in the setting of an abnormal SPECT radionuclide myocardial perfusion imaging (MPI) study is considered a marker of severe and extensive coronary artery disease (CAD). However, the clinical significance of TID and its association with CAD in patients with an otherwise normal MPI study is unclear. METHODS: From a database of patients who underwent MPI over a 9-year period, 96 without known cardiac history who had normal image perfusion patterns, and who underwent coronary angiography within 6 months, were identified. TID quantitative values were derived. To adjust for varying stress and image protocols, a TID index based on published threshold values was derived for each patient, with >1 considered as TID. We examined the relationship of TID to the presence/extent of CAD, and to a CAD prognostic index. TID was also correlated with patient survival. To address referral bias, survival in a separate cohort of 3,691 patients with a normal perfusion MPI who did not undergo angiography in the 6-month interval was correlated with the presence and severity of TID. RESULTS: For 28 (29.2%) patients with normal MPI perfusion patterns but with TID, there was no increased incidence of CAD, multivessel or left main disease, or a higher prognostic index compared with no TID. In addition, there was no increased mortality associated with TID in both the angiography cohort and in the patients who did not undergo immediate angiography. CONCLUSIONS: TID in patients with an otherwise normal SPECT MPI study does not increase the likelihood of CAD, its extent or severity, and is not associated with worsened patient survival.
BACKGROUND: Transient ischemic dilation (TID) in the setting of an abnormal SPECT radionuclide myocardial perfusion imaging (MPI) study is considered a marker of severe and extensive coronary artery disease (CAD). However, the clinical significance of TID and its association with CAD in patients with an otherwise normal MPI study is unclear. METHODS: From a database of patients who underwent MPI over a 9-year period, 96 without known cardiac history who had normal image perfusion patterns, and who underwent coronary angiography within 6 months, were identified. TID quantitative values were derived. To adjust for varying stress and image protocols, a TID index based on published threshold values was derived for each patient, with >1 considered as TID. We examined the relationship of TID to the presence/extent of CAD, and to a CAD prognostic index. TID was also correlated with patient survival. To address referral bias, survival in a separate cohort of 3,691 patients with a normal perfusion MPI who did not undergo angiography in the 6-month interval was correlated with the presence and severity of TID. RESULTS: For 28 (29.2%) patients with normal MPI perfusion patterns but with TID, there was no increased incidence of CAD, multivessel or left main disease, or a higher prognostic index compared with no TID. In addition, there was no increased mortality associated with TID in both the angiography cohort and in the patients who did not undergo immediate angiography. CONCLUSIONS: TID in patients with an otherwise normal SPECT MPI study does not increase the likelihood of CAD, its extent or severity, and is not associated with worsened patient survival.
Authors: Louise Emmett; Michael Magee; S Ben Freedman; Hans Van der Wall; Vivienne Bush; Joseph Trieu; William Van Gaal; Kevin C Allman; Leonard Kritharides Journal: J Nucl Med Date: 2005-10 Impact factor: 10.057
Authors: J R McClellan; M I Travin; S D Herman; J I Baron; R J Golub; J J Gallagher; D Waters; G V Heller Journal: Am J Cardiol Date: 1997-03-01 Impact factor: 2.778
Authors: Daniel S Berman; Leslee J Shaw; Rory Hachamovitch; John D Friedman; Donna M Polk; Sean W Hayes; Louise E J Thomson; Guido Germano; Nathan D Wong; Xingping Kang; Alan Rozanski Journal: Semin Nucl Med Date: 2007-01 Impact factor: 4.446
Authors: D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond Journal: J Am Coll Cardiol Date: 1995-09 Impact factor: 24.094
Authors: A T Weiss; D S Berman; A S Lew; J Nielsen; B Potkin; H J Swan; A Waxman; J Maddahi Journal: J Am Coll Cardiol Date: 1987-04 Impact factor: 24.094
Authors: Andrew J Yoon; Rowlens M Melduni; Shelly-Ann Duncan; Robert J Ostfeld; Mark I Travin Journal: J Nucl Cardiol Date: 2009-03-06 Impact factor: 5.952
Authors: Mohamed A Mandour Ali; Jamieson M Bourque; Adel H Allam; George A Beller; Denny D Watson Journal: J Nucl Cardiol Date: 2011-09-23 Impact factor: 5.952
Authors: Rami Doukky; Nathan Frogge; Yohannes A Bayissa; Gautam Balakrishnan; Jacob M Skelton; Kara Confer; Kalindi Parikh; Russell F Kelly Journal: J Nucl Cardiol Date: 2013-08-09 Impact factor: 5.952
Authors: Rine Nakanishi; Heidi Gransar; Piotr Slomka; Reza Arsanjani; Aryeh Shalev; Yuka Otaki; John D Friedman; Sean W Hayes; Louise E B Thomson; Mathews Fish; Guido Germano; Aiden Abidov; Leslee Shaw; Alan Rozanski; Daniel S Berman Journal: J Nucl Cardiol Date: 2015-05-14 Impact factor: 5.952
Authors: Yuan Xu; Reza Arsanjani; Morgan Clond; Mark Hyun; Mark Lemley; Mathews Fish; Guido Germano; Daniel S Berman; Piotr J Slomka Journal: J Nucl Cardiol Date: 2012-03-08 Impact factor: 5.952
Authors: A Jimenez-Heffernan; E Sanchez de Mora; C Salgado; J Lopez-Martin; C Ramos; E Rodriguez-Gomez; A Tobaruela Journal: J Nucl Cardiol Date: 2012-04-24 Impact factor: 5.952